Epidemiologic evidence on coffee and cancer

Nutrition and Cancer

Volumn 62, Issue 3, 2010, Pages 271-283

  Arab, Lenore ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARCINOGENICITY; CHILDHOOD LEUKEMIA; COFFEE; COLORECTAL CANCER; ENDOMETRIUM CANCER; FOOD INTAKE; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SEX DIFFERENCE; STOMACH CANCER;

COFFEE; FEMALE; HUMANS; MALE; NEOPLASMS; SEX FACTORS;

EID: 77951123183     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903407122     Document Type: Review

References (73)

1. WCRF: Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective, 2007. Available from: http://www. dietandcancerreport.org/
2. Jacobsen BK, Bjelke E, Kvale G, and Heuch I: Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76, 823-831, 1986.
3. Rosengren A and Wilhelmsen L: Coffee, coronary heart disease, and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med 230, 67-71, 1991.
4. Jazbec A, Simíc D, Corovíc N, Durakovíc Z, and Pavlovíc M: Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. J Health Popul Nutr 21, 332-340, 2003.
5. Andersen LF, Jacobs DR Jr, Carlson MH, and Elashoff R: Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nut 83, 1039-1046, 2006.
6. Heyden S, Tyroler HA, Heiss G, Hames CG, and Bartel A: Coffee consumption and mortality: total mortality, strokemortality, and coronary heart disease mortality. Arch Intern Med 138, 1472-1475, 1978.
7. Bidel S, Hu G, Qiao Q, Jousilahti P, Antikainen R, et al.: Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetology 49, 2618-2626, 2006. (Pubitemid 44559523)
8. Stocks P: Cancer mortality in relation to national consumption of cigarettes, solid fuel, tea, and coffee. Br J Cancer 24, 215-225, 1970.
9. Coffee and cancer of the pancreas. N Engl J Med 304, 1604-1606, 1981.
10. Lin RS and Kessler II: A multifactorial model for pancreatic cancer in man: epidemiologic evidence. JAMA 245, 147-152, 1981.
11. MacMahon B, Yen S, Trichopoulos D,Warren K, and Nardi G: Coffee and cancer of the pancreas. N Engl J Med 304, 630-633, 1981.
12. World Health Organization, International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans [monograph online]. Vol.51: Coffee, Tea, Mate, Methylxanthines, and Methylglyoxal, 1991. Available from: http://monographs.iarc. fr/ENG/Monographs/vol51/volume51.pdf
13. Kinlen L, Glodblatt P, Fox J, and Yudkin J: Coffee and pancreas cancer: controversy in part explained? Lancet 8371, 282-283, 1984. (Pubitemid 14178539)
14. Luo J, Inoue M, Iwasaki M, Sasazuki S, Otani T, et al.: Green tea and coffee intake and risk of pancreatic cancer in a large-scale, populationbased cohort study in Japan (JPHC study). Eur J Cancer Prev 16, 542-548, 2007.
15. McLaughlin JK and Lipworth L: Epidemiologic aspects of renal cell cancer. Semen Oncol 27, 115-123, 2000.
16. Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, et al.: Total fluid intake and use of individual beverages and risk of renal cell cancer in two large cohorts. Cancer Epidemiol Biomarkers Prev 15, 1204-1211, 2006.
17. Bravi F, Bosetti C, Scotti L, Talamini R, Montella M, et al.: Food groups and renal cell carcinoma: a case-control study from Italy. Int J Cancer 120, 681-685, 2007. (Pubitemid 44969041)
18. Lee JE, Hunter DJ, Spiegelman D, Adami HO, Bernstein L, et al.: Intakes of coffee, tea, milk, soda, and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer 121, 2246-2253, 2007.
19. Tavani A and La Vecchia C: Coffee, decaffeinated coffee, tea, and cancer of the colon and rectum: a review of epidemiological studies 1990-2003. Cancer Causes Control 15, 743-757, 2004.
20. Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, et al.: The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett 244, 260-267, 2006.
21. LeeKJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, et al.:Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 121, 1312-1318, 2007. (Pubitemid 47293799)
22. Hirvonen T, Mennen LI, de Bree A, Castetbon K, Galan P, et al.: Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol 16, 503-508, 2006.
23. Michels KB, Holmberg L, Bergkvist L, and Wolk A: Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Ann Epidemiol 12, 21-26, 2002.
24. Tavani A, Pregnolato A, La Vecchia C, Favero A, and Franceschi S: Coffee consumption and the risk of breast cancer. Eur J Cancer Prev 7, 77-82, 1998.
25. Baker JA, Beehler GP, Sawant AC, Jayaprakash V, McCann SE, et al.: Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136, 166-171, 2006.
26. Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, et al.: Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 118, 103-107, 2006. (Pubitemid 41681585)
27. Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, et al.: The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16, 912-916, 2007.
28. Hirose K, Niwa Y, Wakai K, Matsuo K, Nakanishi T, et al.: Coffee consumption and the risk of endometrial cancer: evidence from a case-control study of female hormone-related cancers in Japan. Cancer Sci 98, 411-415, 2007.
29. Terry P, Vainio H, Wolk A, and Weiderpass E: Dietary factors in relation to endometrial cancer: a nationwide case-control study in Sweden. Nutr Cancer 42, 25-32, 2002. (Pubitemid 35007003)
30. Bravi F, Scotti L, Bosetti C, Zucchetto A, Talamini R, et al.: Food groups and endometrial cancer risk: a case-control study from Italy. Am J Obstet Gynecol 200, e1-7, 2009.
31. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Kurahashi N, et al.: Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 123, 2406-2410, 2008.
32. Koizumi T, Nakaya N, Okamura C, Sato Y, Shimazu T, et al.: Case-control study of coffee consumption and the risk of endometrial endometrioid adenocarcinoma. Eur J Cancer Prev 17, 358-363, 2008.
33. Silvera SA, Jain M, Howe GR, Miller AB, and Rohan TE: Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study. Nutr Cancer 58, 22-27, 2007. (Pubitemid 47076158)
34. Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, and van den Brandt PA: Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 97, 1291-1294, 2007.
35. Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, et al.: Consumption of black tea or coffee and risk of ovarian cancer. Int J Gynecol Cancer 17, 50-54, 2007.
36. LeeKJ, Choi JH, and Jeong HG: Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 45, 2118-2125, 2007.
37. Klatsky AL, Morton C, Udaltsova N, and Friedman GD: Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166, 1190-1195, 2006.
38. Homan DJ and Mobarhan S: Coffee: good, bad, or just fun? a critical review of coffee's effects on liver enzymes. Nutr Rev 64, 43-46, 2006.
39. Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, et al.: Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46, 430-435, 2007.
40. Larsson SC and Wolk A: Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 132, 1740-1745, 2007. (Pubitemid 46677953)
41. Inoue M, Yoshimi I, Sobue T, and Tsugane S for the JPHC Study Group: Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97, 293-300, 2005.
42. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, et al.: Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 93, 607-610, 2005.
43. Tanaka K, Hara M, Sakamoto T, Higaki Y, Mizuta T, et al.: Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a CC study in Japan. Cancer Sci 98, 214-218, 2007.
44. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, et al.: Risk factors for hepatocellular carcinoma in a Japanese population: a nested CC study. Cancer Epidemiol Biomarkers Prev 17, 846-854, 2008.
45. Wakai K, Kurozawa Y, Shibata A, Fujita Y, Kotani K, et al.: Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan. Br J Cancer 97, 426-428, 2007.
46. Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, et al.: Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 42, 528-534, 2005.
47. Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, et al.: Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 120, 1555-1559, 2007. (Pubitemid 46355393)
48. Zeegers MP, Tan FE, Goldbohm RA, and van den Brandt PA: Are coffee and tea consumption associated with urinary tract cancer risk? a systematic review and meta-analysis. Int J Epidemiol 30, 353-362, 2001.
49. Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, et al.: Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 118, 2040-2047, 2006.
50. De Stefani E, Boffetta P, Deneo-Pellegrini H, Correa P, Ronco AL, et al.: Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer 7, 57, 2007.
51. Ugnat AM, Luo W, Semenciw R, and Mao Y: Canadian Cancer Registries Epidemiology Research Group occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces. Chronic Dis Can 25, 7-15, 2004.
52. Pelucchi C and La Vecchia C: Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies. Eur J Cancer Prev 18, 62-68, 2009.
53. Botelho F, Lunet N, and Barros H: Coffee and gastric cancer: systematic review and meta-analysis. Cad Saude Publica 22, 889-900, 2006.
54. Larsson SC, Giovannucci E, andWolk A: Coffee consumption and stomach cancer risk in a cohort of Swedish women. Int J Cancer 119, 2186-2189, 2006. (Pubitemid 44423679)
55. Peters JM, Preston-Martin S, London SJ, Bowman JD, Buckley JD, et al.: Processed meats and risk of childhood leukemia (California, USA). Cancer Causes Control 5, 195-202, 1994.
56. Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, et al.: The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 76, 1241-1247, 1997.
57. Menegaux F, Steffen C, Bellec S, Baruchel A, Lescoeur B, et al.: Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemia. Cancer Detect Prev 29, 487-493, 2005.
58. Menegaux F, Ripert M,H́emon D, and Clavel J:Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French populationbased case-control study. Paediatr Perinat Epidemiol 21, 293-299, 2007.
59. Stocks P: Cancer mortality in relation to national consumption of cigarettes, solid fuel, tea, and coffee. Br J Cancer 24, 215-225, 1970.
60. Ganmaa D, Li XM, Wang J, Qin LQ, Wang PY, et al.: Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer 98, 262-267, 2002.
61. Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, et al.: Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50, 6836-6840, 1990.
62. Whittemore AS, Paffenbarger RS Jr., Anderson K, and Lee JE: Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst 74, 43-51, 1985.
63. Jain MG, Hislop GT, Howe GR, Burch JD, and Ghadirian P: Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78, 707-711, 1998.
64. Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, et al.: Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 80, 699-703, 1999.
65. Slattery ML and West DW: Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States). Cancer Causes Control 4, 559-563, 1993.
66. Sharpe CR and Siemiatycki J: Consumption of non-alcoholic beverages and prostate cancer risk. Eur J Cancer Prev 11, 497-501, 2002.
67. Ellison LF: Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9, 125-130, 2000.
68. Post SM, de Roos B, Vermeulen M, Afman L, Jong MC, et al.: Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis. Arterioscler Thromb Vasc Biol 20, 1551-1556, 2000.
69. Post SM, de Wit EC, and Princen HM: Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol 17, 3064-3070, 1997.
70. Lee WJ and Zhu BT: Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27, 269-277, 2006.
71. Bode AM and Dong Z: The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247, 26-39, 2007.
72. CamouseMM,Hanneman KK, Conrad EP, and Baron ED: Protective effects of tea polyphenols and caffeine. Expert Rev Anticancer Ther 5, 1061-1068, 2005.
73. Ito K, Nakazato T, Miyakawa Y, Yamato K, Ikeda Y, et al.: Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells. J Cell Physiol 196, 276-283, 2003.